Keith E Sheridan

US Patent:

20120185264, Jul 19, 2012

Filed:

Jan 18, 2011

Appl. No.:

13/008102

Inventors:

PETER DEMOGENES - Scottsdale AZ, US
JEFFREY LITTLE - Tempe AZ, US
KARIN CHUN HAYES - Mesa AZ, US
KEITH SHERIDAN - East Greenwich RI, US
PAULETTE WEIDMAN - Peoria AZ, US

Assignee:

SOURCE HEALTHCARE ANALYTICS, INC. - Phoenix AZ

International Classification:

G06Q 50/00
G06Q 10/00

US Classification:

705 2

Abstract:

A prescription association system and method for grouping together prescription-related transactions and creating groups or “clusters” of prescriptions having similar characteristics. Through an association process, the prescription cluster describes the events surrounding prescription activity. This includes prescribing patterns, payer influences, and patient acceptance of therapy. The same prescription transaction from one data provider may contain additional or different information that can enhance a corresponding duplicate transaction or set of claim lifecycle transactions from another provider. The disclosed processes create unique linking across claims, payers, and patients and form the basis for relating and measuring payer, patient, practitioner, and pharmaceutical promotion influences on healthcare utilization and treatment.

US Patent:

20160103976, Apr 14, 2016

Filed:

Dec 17, 2015

Appl. No.:

14/973065

Inventors:

- Phoenix AZ, US
KARIN CHUN HAYES - Mesa AZ, US
JEFFREY LITTLE - Tempe AZ, US
KEITH SHERIDAN - East Greenwich RI, US
PAULETTE WEIDMAN - Peoria AZ, US

International Classification:

G06F 19/00

Abstract:

A prescription association system and method for grouping together prescription-related transactions and creating groups or “clusters” of prescriptions having similar characteristics. Through an association process, the prescription cluster describes the events surrounding prescription activity. This includes prescribing patterns, payer influences, and patient acceptance of therapy. The same prescription transaction from one data provider may contain additional or different information that can enhance a corresponding duplicate transaction or set of claim lifecycle transactions from another provider. The disclosed processes create unique linking across claims, payers, and patients and form the basis for relating and measuring payer, patient, practitioner, and pharmaceutical promotion influences on healthcare utilization and treatment.